Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Human Iba1 ELISA Kit (AC3894)
Cat.#: ASET-2483
Specifications
Description Human Iba1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human Iba1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 1.39 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 30-480 ng/mL Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1300 Mouse Metabotropic Glutamate Receptor 5 ELISA Kit (AC2711) Quantitative inquiry ASET-2174 Mouse Dopamine ELISA Kit (AC3585) Quantitative inquiry ASET-1194 Human VAMP2 ELISA Kit (AC2605) Quantitative inquiry ASET-2316 Rat IL-6 ELISA Kit (AC3727) Quantitative inquiry ASET-1612 Human Nyctalopin ELISA Kit (AC3023) Quantitative inquiry ASET-1089 Human Profilin 1 ELISA Kit (AC2500) Quantitative inquiry ASET-1593 Canine Insulin ELISA Kit (AC3004) Quantitative inquiry ASET-1206 Human Substance P ELISA Kit (AC2617) Quantitative inquiry ASET-2503 Rat Heme Oxygenase 1 ELISA Kit (AC3914) Quantitative inquiry ASET-1179 Human SRPX2 ELISA Kit (AC2590) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket